BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10477000)

  • 1. Results of proton therapy of uveal melanomas treated in Nice.
    Courdi A; Caujolle JP; Grange JD; Diallo-Rosier L; Sahel J; Bacin F; Zur C; Gastaud P; Iborra-Brassart N; Hérault J; Chauvel P
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):5-11. PubMed ID: 10477000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
    Caujolle JP; Mammar H; Chamorey E; Pinon F; Herault J; Gastaud P
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):98-103. PubMed ID: 19910136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma.
    Egger E; Schalenbourg A; Zografos L; Bercher L; Boehringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):138-47. PubMed ID: 11516863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project).
    Spatola C; Privitera G; Raffaele L; Salamone V; Cuttone G; Cirrone P; Sabini MG; Lo Nigro S
    Tumori; 2003; 89(5):502-9. PubMed ID: 14870772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
    Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
    J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France.
    Mosci C; Mosci S; Barla A; Squarcia S; Chauvel P; Iborra N
    Eur J Ophthalmol; 2009; 19(4):654-60. PubMed ID: 19551683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye retention after proton beam radiotherapy for uveal melanoma.
    Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
    Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma.
    Li W; Gragoudas ES; Egan KM
    Arch Ophthalmol; 2000 Aug; 118(8):1066-70. PubMed ID: 10922199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of proton therapy for the treatment of uveal metastases.
    Kamran SC; Collier JM; Lane AM; Kim I; Niemierko A; Chen YL; MacDonald SM; Munzenrider JE; Gragoudas E; Shih HA
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1044-50. PubMed ID: 25442038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.
    Thariat J; Maschi C; Lanteri S; Peyrichon ML; Baillif S; Herault J; Salleron J; Caujolle JP
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):142-151. PubMed ID: 28586953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
    Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
    Ophthalmology; 2013 Oct; 120(10):2066-71. PubMed ID: 23664467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Masked Randomized Phase 2 Study Assessing 2 Forms of Hypofractionated Proton Therapy in Patients With Large Choroidal Melanomas.
    Thariat J; Mathis T; Pace-Loscos T; Peyrichon ML; Maschi C; Rosier L; Nguyen M; Bonnin N; Aloi D; Gastaud L; Gaucher D; Caujolle JP; Château Y; Herault J
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):357-369. PubMed ID: 37257661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.